The Rise and Thrive of REX American Resources: A Resilient Victory Amidst Stock Market Turbulence

Painting a picture of optimism, U.S. stocks inched higher, with the S&P 500 edging up about 0.1% on Thursday.

In a sweeping momentum, REX American Resources Corporation REX surged during Thursday’s trading session following stellar quarterly earnings that outpaced market expectations.

Reports indicate that REX American Resources unveiled quarterly GAAP earnings of $1.16 per share, trumping market projections of 68 cents per share, courtesy of data from Benzinga Pro.

In a breathtaking leap, REX American Resources shares soared by 23.2%, settling at $54.15 on Thursday.

Ensuing the meteoric rise of REX American Resources, other prominent stocks also basked in the glow of upward movement on this trading day.

• Avalo Therapeutics, Inc. AVTX saw a monumental 430% spike to $25.35 following the acquisition of a Phase 2-ready anti-IL-1β mAb, AVTX-009, through the acquisition of AlmataBio. Further bolstering its position, the company announced a private placement financing of up to $185 million.
• Hut 8 Corp. HUT surged an impressive 20.4% to $11.87. Noteworthy for reporting revenue of C$60.6 million for the six months ending Dec. 31, 2023.
• RH RH advanced by 16.2% to $344.99, buoyed by the release of its quarterly results. While the company faced a setback with weaker-than-expected fourth-quarter results, the revelation of an optimistic forecast ignited investor interest.
• Sutro Biopharma, Inc. STRO witnessed a remarkable 14.4% climb to $5.64. Notably, Oppenheimer analyst Jay Olson maintained an Outperform rating and a $10 price target for Sutro Biopharma.
• Nikola Corporation NKLA rose by 12.7% to $1.0250.
• OPKO Health, Inc. OPK escalated by 12.1% to $1.1996. The acquisition of select assets of BioReference Health’s Diagnostics Business by Labcorp fueled this substantial growth.
• Altimmune, Inc. ALT thrived with an 11.4% gain, reaching $9.90. Altimmune recently shared promising lean mass preservation data for pemvidutide alongside fourth-quarter FY23 earnings that fell below expectations.
• Marathon Digital Holdings, Inc. MARA ascended by 10.4% to $24.37.
• Guardant Health, Inc. GH achieved an 8.4% uptick to $19.48.
• Opendoor Technologies Inc. OPEN surged by 8% to $3.1850.
• Arhaus, Inc. ARHS advanced by 7.7% to $15.94.
• Riot Platforms, Inc. RIOT climbed by 6.8% to $13.07.
• BRP Inc. DOOO witnessed a 6.4% increase to $67.74 after publishing its fourth-quarter results.
• Encompass Health Corporation EHC saw a 5.8% rise to $82.06. In a testament to its confidence in the company’s future, Barclays analyst Andrew Mok maintained an Overweight rating and lifted the price target from $95 to $101.
• The Estée Lauder Companies Inc. EL surged by 5.4% to $152.85 following an upgrade from Neutral to Buy by B of A Securities, accompanied by a price target increase from $160 to $170.
• Exact Sciences Corporation EXAS gained 4.7% to $70.01.

Unlocking a vivid tapestry of stock market movements, this day has unveiled a thrilling narrative.